COVID-19 Daily News: April 22

Mayo Clinic expert answers questions about antibody testing for COVID-19

A new serology, or antibody, test for COVID-19 has been developed and is now in use by Mayo Clinic Laboratories. Unlike the molecular diagnostic test for COVID-19, which determines if someone is currently infected with the SARS-CoV-2, the virus that causes COVID-19, serology tests detect a patient's immune response to the virus by specifically looking for antibodies developed against the virus. These antibodies will attach to and essentially kill the virus.

Read more.


Mayo Clinic Q&A podcast: COVID-19 research task force

As the SARS-CoV-2 virus spread worldwide, a race began to develop testing protocols and ramp up research. Mayo Clinic's COVID-19 research task force is studying the virus, predicting hot spots, and working towards effective treatments and a vaccine.

Read more.


Why a Mayo Clinic expert has grave concerns about second wave of COVID-19

As states look toward beginning to reopen their economies, health experts are warning of a possible second wave of COVID-19 that could emerge later this year and make for an even more dire health crisis.

Read more.


COVID-19: New daily routines for medications

"Set a reminder on your smartphone, or someplace in your house, or post sticky notes to tie those medications to something else you're doing, to remind you," Dr. Bright says. "Put the prescription bottle next to your toothbrush, so when you get up in the morning and go to bed at night, you see the medicine right there."

Read more.

Samantha Rossi

Samantha Rossi

Samantha Rossi is a Marketing Associate at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.